Genmab — November 2020

Sukkeralf

Men bare hun er klog og har styr på tingene, så går det nok !

Solsen

Vi mangler SBs linier. Havde vi en linie heromkring ?

Sukkeralf

SB?

Solsen

Stockbull

Solsen

Target 2580 https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/87738_genmab_2237.JPG

Solsen

https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/87741_target_2580_gmab.JPG Det var til nytår at target var 2580. Men vi er over den linie nu i november. Prøv at aflæse næste niveau

Plimsoller

Target fo
r 2020 er 2700 Solsen

E_L

that is not a bad guess really, there is a nice AB=CD at 2722 and a 1.618 extension at
2720

Plimsoller

And equally good for the wallet

E_L

larger trendline resistance really only above 2900

Solsen

I think if Tapezza, Kesimpta, Darzalex still performing excellent. Amivantamab and TF is on its way to approval we reach a milestone with 3.000 DKK in 2021.

Sukkeralf

I agree.................and if a BsAb like PD-L1/4-1BB with the magnitude of 10 billion dollars or higher starts to show off then its hard to guess were we are going

Sukkeralf

early days still but valuation comes also early these days

StockBull

https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/88181_genmab_rykker.JPG Tror vi skal op og ligge og swinge mellem 2350 til 2650 kommende måneder. Har indikeret en mindre stejl kurve. Har selvfølgelig ikke ikke noget imod Genmab forbliver i den stejle kurve

Helge_LarsenPI-redaktør

Genmab/CEO: Darzalex suppleres af flere nye trækheste i 2021
https://www.proinvestor.com/investornyt/669340/genmab-ceo-darzalex-suppleres-af-flere-nye-traekheste-i-2021

Solsen

Du var sekundet hurtigere Helge. Bid mærke i, at JW forventer pæne indtægter fra Amivantamab i 2021.

E_L

did he not also compare Epcoritamab
to Dara in an interview or am i wrong now?

Solsen

Yes we forgot Epco Judith did tell that they will persude all b-cell indications.

Solsen

As I recall

E_L

and dont forget Dara , many abstracts at ASH and